Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ruzza

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 25, 2014
[Late complication after Roux-en-Y gastric bypass: Unusual finding]Y Fringeli, A Metzger, C Ruzza, et al.
Peptides|July 13, 2017
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin testA Rizzi, C Ruzza, S Bianco, et al.
Neuropharmacology|January 18, 2012
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptorC Ruzza, A Pulga, A Rizzi, et al.
Frontiers in Pharmacology|November 30, 2023
<i>In vitro</i> pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assayC Ruzza, M Argentieri, F Ferrari, et al.
Peptides|August 6, 2013
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1V Camarda, C Ruzza, A Rizzi, et al.
British Journal of Pharmacology|April 1, 2008
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in miceA Rizzi, R Vergura, G Marzola, et al.
British Journal of Pharmacology|April 2, 2015
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeysA Rizzi, D D Sukhtankar, H Ding, et al.
Neuropharmacology|February 13, 2016
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligandsL Asth, C Ruzza, D Malfacini, et al.
Die Pharmazie|July 31, 2014
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acidM Pelà, L Del Zoppo, L Allegri, et al.
British Journal of Pharmacology|June 7, 2014
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivativesA Rizzi, D Malfacini, M C Cerlesi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 25, 2014
[Late complication after Roux-en-Y gastric bypass: Unusual finding]Y Fringeli, A Metzger, C Ruzza, et al.
Peptides|July 13, 2017
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin testA Rizzi, C Ruzza, S Bianco, et al.
Neuropharmacology|January 18, 2012
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptorC Ruzza, A Pulga, A Rizzi, et al.
Frontiers in Pharmacology|November 30, 2023
<i>In vitro</i> pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assayC Ruzza, M Argentieri, F Ferrari, et al.
Peptides|August 6, 2013
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1V Camarda, C Ruzza, A Rizzi, et al.
British Journal of Pharmacology|April 1, 2008
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in miceA Rizzi, R Vergura, G Marzola, et al.
British Journal of Pharmacology|April 2, 2015
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeysA Rizzi, D D Sukhtankar, H Ding, et al.
Neuropharmacology|February 13, 2016
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligandsL Asth, C Ruzza, D Malfacini, et al.
Die Pharmazie|July 31, 2014
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acidM Pelà, L Del Zoppo, L Allegri, et al.
British Journal of Pharmacology|June 7, 2014
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivativesA Rizzi, D Malfacini, M C Cerlesi, et al.
Pageof 2